Noninvasive determination of endothelium-mediated vasodilation as a screening test for coronary artery disease: Pilot study to assess the predictive value in comparison with angina pectoris, exercise electrocardiography, and myocardial perfusion imaging

American Heart Journal

Volumn 138, Issue 4 I, 1999, Pages 731-739

  Schroeder, S ^a   Enderle, M D ^a   Ossen, R ^a   Meisner, C ^a   Baumbach, A ^a   Pfohl, M ^a   Herdeg, C ^a   Oberhoff, M ^a   Haering, H U ^a   Karsch, K R ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; NITRATE;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; CORONARY ARTERY DISEASE; DIAGNOSTIC VALUE; EXERCISE ELECTROCARDIOGRAPHY; FEMALE; HEART MUSCLE PERFUSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM; VASODILATATION;

EID: 0032886689     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(99)70189-4     Document Type: Article

References (28)

1. Luscher TF, Noll G. Endothelial dysfunction in the coronary circulation. J Cardiovasc Pharmacol 1994;24(suppl 3):S16-26.
2. Cohen R. The role of nitric oxide and other endothelium derived vasoactive substances in vascular disease. Prog Cardiovasc Dis 1995;38:105-28.
3. Mondaca S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 1991;43:109-42.
4. Yanagisawa M, Kurihara H, Kimura S, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988;332:411-5.
5. Drexler H. Endothelial dysfunction: clinical implications. Prog Cardiovasc Dis 1997;39:287-324.
6. Clarkson P, Celermajer DS, Donald AE, et al. Impaired vascular reactivity in insulin-dependent diabetes mellitus is related to disease duration and low density lipoprotein cholesterol levels. J Am Coll Cardiol 1996;28:573-9.
7. Enderle MD, Benda N, Schmülling RM, et al. Preserved endothelial function compared with healthy subjects in IDDM patients but not in NIDDM patients. Diabetes Care 1998;21:271-7.
8. Enderle MD, Balletshofer BM, Schmuelling RM, et al. Early detection of atherosclerosis in type 2 diabetic patients using high resolution ultrasound. Ultraschall Med 1998;19:16-21.
9. Anderson TJ, Overhiser RW, Haber H, et al. A comparative study of 4 antihypertensive agents on endothelial function in patients with coronary artery disease [abstract]. J Am Coll Cardiol 1998;31:327A.
10. Enderle MD, Pfohl M, Kellermann N, et al. In smokers endothelial dysfunction precedes alterations in coagulation and fibrinolysis [abstract]. Eur Heart J 1998;19:105A.
11. Zeiher AM, Drexler H, Wollschläger H, et al. Modulation of coronary vasomotor tone in humans: progressive endothelial dysfunction with different early stages of coronary atherosclerosis. Circulation 1991;83:391-401.
12. Hodgson JM, Marshall JJ. Direct vasoconstriction and endothelium dependent vasodilation: mechanisms of acetyl effects on coronary flow and arterial diameter in patients with nonstenotic coronary arteries. Circulation 1989;79:1043-51.
13. Anderson TJ, Uehata A, Gerhard MD, et al. Close relation of endothelial function in the human coronary artery and peripheral circulations. J Am Coll Cardiol 1995;26:1235-41.
14. Takase B, Akima T, Uehata A, et al. Close relation between endothelium-dependent flow-mediated vasodilation in coronary and brachial artery in human [abstract]. J Am Coll Cardiol 1998;31:359A.
15. Celermajer DS, Sorensen KE, Gooch VM, et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992;340:1111-5.
16. Celermajer D, Adams M, Clarkson P, et al. Passive smoking and impaired endothelium-dependent arterial dilation in healthy young adults N Engl J Med 1996;334:150-4.
17. Celermajer DS, Sorensen KE, Bull C, et al. Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. J Am Coll Cardiol 1994;24:1468-74.
18. Neunteufl T, Katzenschlager R, Hassan A, et al. Systemic endothelial dysfunction is related to the extent and severity of coronary artery disease. Atherosclerosis 1997;129:111-8.
19. Enderle MD, Schröder S, Ossen R, et al. A comparison of peripheral endothelial dysfunction and intima media thickness in patients with suspected coronary artery disease. Heart 1998;80:349-54.
20. Wendelhag I, Gustavsson T, Suurkula M, et al. Ultrasound measurement of wall thickness in the carotid artery: fundamental principles and description of computerised analysing system. Clin Physiol 1991;11:565-77.
21. Celermajer D. Endothelial dysfunction: does it matter? Is it reversible? J Am Coll Cardiol 1997;30:325-33.
22. Gianrossi R, Detrano R, Mulvihill, et al. Exercise-induced ST depression in the diagnosis of coronary heart disease: a meta-analysis. Circulation 1989;80:87-90.
23. Motoyama T, Kawano H, Kugiyama K, et al. Flow-mediated, endothelium-dependent dilation of the brachial arteries is impaired in patients with coronary spastic angina. Am Heart J 1997;133:263-7.
24. Douglas PS. Is noninvasive testing for coronary artery disease accurate? Circulation 1997;95:299-302.
25. Stroes ESG, Koomans HA, Bruin TWA, et al. Vascular function in the forearm of hypercholesterolemic patients off and on lipid-lowering drug. Lancet 1995;346:467-71.
26. Treasure CB, Klein JL, Weintraub WS, et al. Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease. N Engl J Med 1995;332:481-7.
27. Vaughan CJ, Murphy MB, Buckley BM. Statins do more than just lower cholesterol. Lancet 1996;348:1079-82.
28. Tilkemeier PL, Katz AS, Parisi AF. The role of non-invasive testing in evaluating patients of coronary artery disease. Curr Opin Cardiol 1996;11:409-17.